The overexpression of α-synuclein
(α-syn) and its aggregation
is the hallmark of Parkinson’s disease. The α-syn aggregation
results in the formation of Lewy bodies that causes neuronal cell
death. Therefore, the small molecules that can protect neuronal cells
from α-syn toxicity or inhibit the aggregation of α-syn
could emerge as anti-Parkinson agents. Herein, a library of methoxy-stilbenes
was screened for their ability to restore the cell growth from α-syn
toxicity, using a yeast strain that stably expresses two copies of
a chromosomally integrated human α-syn gene. Tetramethoxy-stilbene
4s
, a nonantioxidant, was the most capable of restoring cell
growth. It also rescues the more toxic cells that bear three copies
of wild-type or A53T-mutant α-syn, from cell growth block. Its
EC
50
values for growth restoration of the 2-copy wild-type
and the 3-copy mutant α-syn strains are 0.95 and 0.35 μM,
respectively. Stilbene
4s
mitigates mitochondrial membrane
potential loss, negates ROS production, and prevents nuclear DNA-fragmentation,
all hallmarks of apoptosis. However,
4s
does not rescue
cells from the death-inducing effects of Bax and βA4, which
suggest that
4s
specifically inhibits α-syn-mediated
toxicity in the yeast. Our results signify that simultaneous use of
multiple yeast-cell-based screens can facilitate revelation of compounds
that may have the potential for further investigation as anti-Parkinson’s
agents.